HomeNURPF • OTCMKTS
add
Neuren Pharmaceuticals Ltd
Previous close
$8.53
Year range
$6.60 - $14.80
Market cap
1.59B AUD
Avg Volume
234.00
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 18.19M | -80.92% |
Operating expense | 20.06M | 1,624.41% |
Net income | 7.70M | -88.51% |
Net profit margin | 42.35 | -39.78% |
Earnings per share | — | — |
EBITDA | 5.58M | -93.56% |
Effective tax rate | 19.80% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 296.12M | 33.24% |
Total assets | 342.86M | -16.32% |
Total liabilities | 4.40M | -90.38% |
Total equity | 338.45M | — |
Shares outstanding | 126.64M | — |
Price to book | 3.19 | — |
Return on assets | 4.06% | — |
Return on capital | 4.11% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 7.70M | -88.51% |
Cash from operations | -1.44M | -131.12% |
Cash from investing | -1.22M | -173.89% |
Cash from financing | 2.49M | 147.83% |
Net change in cash | -839.50K | -388.49% |
Free cash flow | 5.05M | -90.71% |
About
CEO
Founded
2001
Website
Employees
8
